Carcinoma Breast Clinical Trial
Official title:
Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast.
By this non-randomized prospective study, it's evaluated the outcome of patients underwent
BCS for DCIS at whom an established score system to address adjuvant therapies have been
prospectively applied, according to the wideness of free margins.
Between March 2000 and April 2006, 224 patients were enrolled and followed within the study.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05507034 -
Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.
|
||
| Not yet recruiting |
NCT05603013 -
Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)
|
Phase 2 | |
| Completed |
NCT01849133 -
Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External Radiotherapy
|
N/A | |
| Not yet recruiting |
NCT04985357 -
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs
|
||
| Recruiting |
NCT04790305 -
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
|
Phase 4 | |
| Completed |
NCT03113825 -
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
|
Phase 2 | |
| Recruiting |
NCT05461430 -
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
|
||
| Active, not recruiting |
NCT03768492 -
Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy
|
Phase 2 |